- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01136837
The Prognostic Significance of a Fragmented QRS Complex After Primary Percutaneous Coronary Intervention
June 3, 2010 updated by: Bursa Postgraduate Hospital
To investigate the prognostic significance of a fragmented QRS (fQRS) complex in a patient who had undergone primary percutaneous coronary intervention (PCI).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
85
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bursa, Turkey, 16330
- Bursa Yüksek İhtisas Hastanesi
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
patients who presented to the hospital within 12 hours of the onset of chest pain who were admitted to the coronary intensive care unit (ICU) with the diagnosis of acute STEMI and who were administered primary PCI.
Having acute STEMI for the first time was stipulated for inclusion in the study.
Description
Inclusion Criteria:
- Patients with chest pain that continued longer than 30 minutes and with ≥ 2 mm ST elevation in ECG at least in two adjacent derivations were diagnosed with an acute STEMI. In all patients, at least two-fold increases were seen in serum CK-MB levels compared to normal values.Having acute STEMI for the first time was stipulated for inclusion in the study.
Exclusion Criteria:
- Subjects with known allergies to aspirin and clopidogrel, inadequate echocardiographic images, malignancy, a previous cerebrovascular event, renal dysfunction (creatine level > 2.5 mg/dl), a previous MI, or a history of cardiogenic shock as well as those who refused to participate in the study were excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
fragmented QRS positive
fQRS at 48 hours after Primary PCI
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
---|---|
Major Adverse Cardiac Events
|
the presence of a fQRS at 48 hours after primary PCI is a significant parameter in predicting adverse cardiovascular events;
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
---|---|
Q Wave and QRS distortion for predicting major adverse cardiac events
|
the presence of a fQRS is a more sensitive and specific parameter in predicting development of adverse cardiovascular events than Q wave and QRS distortion; and compared to Q wave, fQRS correlated more significantly with the presence of a scar
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2008
Primary Completion (Actual)
May 1, 2009
Study Completion (Actual)
May 1, 2009
Study Registration Dates
First Submitted
June 2, 2010
First Submitted That Met QC Criteria
June 3, 2010
First Posted (Estimate)
June 4, 2010
Study Record Updates
Last Update Posted (Estimate)
June 4, 2010
Last Update Submitted That Met QC Criteria
June 3, 2010
Last Verified
November 1, 2008
More Information
Terms related to this study
Other Study ID Numbers
- BYİEAH-3
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Primary PCI
-
Qilu Hospital of Shandong UniversityNot yet recruitingPrimary PCI
-
University of PisaCompleted
-
AstraZenecaWithdrawn
-
Pedro A. LemosImperial College London; Cardialysis B.V.Unknown
-
Örebro University, SwedenCompletedPCI | Coronary StentsSweden
-
Rambam Health Care CampusUnknown
-
Beijing Anzhen HospitalRecruitingHigh-risk PCI | ECMOChina
-
Asan Medical CenterKorea Medical Device Development Fund; Medipixel,IncActive, not recruitingCoronary Vessels | Procedure PCIKorea, Republic of
-
Fondazione GISE OnlusUniversity of Padova; Abiomed Inc.Recruiting
-
Abiomed Inc.CompletedPatients Undergoing High Risk PCI.United States, Netherlands
Clinical Trials on primary pcı
-
Carlos III Health InstituteHealth Department of the Basque GovernmentCompleted
-
University Hospital Bispebjerg and FrederiksbergNot yet recruitingNeuropathic Pain | Opioid Use | Arthritis Knee | Persistent Postsurgical Pain
-
Rio de Janeiro State UniversityUniversity of Copenhagen; Oswaldo Cruz Foundation; Universidade Federal do Rio...Suspended
-
University Hospital, BonnUnknownParoxysmal Atrial Fibrillation
-
Minneapolis Heart Institute FoundationNational Heart, Lung, and Blood Institute (NHLBI)CompletedAcute Myocardial InfarctionUnited States
-
University of LouisvilleCompleted
-
Instituto Nacional de Cardiologia Ignacio ChavezCompletedMyocardial Infarction, AcuteMexico
-
University of Maryland, BaltimoreCompleted
-
Norwegian University of Science and TechnologyCompleted
-
University Hospital Bispebjerg and FrederiksbergCompletedNeuropathic Pain | Opioid Use | Persistent Postsurgical Pain | Arthritis HipDenmark